inotuzumab
pfizer,ucb pharmaceuticals
['#all ,(-alli),(-allogenic)', 'inotuzumab', 'leusm']
congress | #ash22 | poster of presents results from a registry-based observation study regarding veno-occlusive disease risk and other outcomes in patients with b-cell precursor #all who received inotuzumab ozogamicin &amp; proceeded to hsct. #allsm #leusm 
A global education platform providing clinical updates on acute lymphoblastic leukemia. #leusm #allsm